Top news of the week: 30.09.2021.
Career And Jobs
Top 10 US Biopharma Series A Rounds of 2021 – So Far!
The United States has seen companies launching left and right. Check out the top 10 biopharma Series A rounds in the U.S. so far this year.
Students, Venture Capitalists Launch Equity-Free Program To Support Future Biotech Leaders
Nucleate, the non-profit organization seeking to support future leaders in the life sciences industry, announced its official launch and immediately opened applications to its Activator ...
UPDATE: Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain
Editas has confirmed safety—and its concept—in a small group of patients who have received the gene-editing therapy EDIT-101. The small amount of data also suggests that the middle dose ...
BioSpace Movers & Shakers, Sept. 24
Life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
An In-Depth Look at Innovation on Cancer Research Day
September 24 is World Cancer Research Day, a time for patients, caregivers and companies on the forefront of cancer R&D to look back and look ahead.
AstraZeneca Buys Caelum BioSciences in $500 Million Deal
AstraZeneca’s Alexion plans to buy all remaining equity in Caelum Biosciences and pick up Caelum’s CAEL-101 in the process.
Implications of the Elizabeth Holmes Trial on High-Risk Fundraising in Silicon Valley
Industry watchers question why Elizabeth Holmes has been singled out for failing to deliver what she promised while other tech executives are given a pass.
Clinical Catch-Up: September 20-24
There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.